Successful management of MRSA sepsis in a patient with left ventricular assist device.

Alejnik I, Hoffmann J, Scheld HH, Vahlhaus C, Klotz S, Hoffmeier A, Schmidt C, Sindermann JR

Abstract

Left ventricular assist devices (LVADs) offer the opportunity to substantially improve the clinical conditions and to interrupt hospitalization of patients suffering from end-stage heart failure awaiting heart transplantation. The authors report a case of a 66-year old patient suffering from end-stage idiopathic dilative cardiomyopathy who needed the implantation of a LVAD and later developed a sepsis with a methicillin resistant Staphylococcus aureus (MRSA) which could be recovered by a differentiated antibiotic regimen.